Clinical Trials Directory

Trials / Unknown

UnknownNCT04381351

Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction

The Role of Noncoding RNAs in COVID-19 and COVID-19 Associated Acute Kidney Injury (MiRCOVID)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Heinrich-Heine University, Duesseldorf · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

In this study, critically ill patients with highly suspected or confirmed COVID-19 will be included. Main goal is the identification of noncoding RNAs in COVID-19 associated organ dysfunction with an emphasis on acute kidney injury.

Conditions

Timeline

Start date
2020-04-16
Primary completion
2021-03-01
Completion
2021-07-31
First posted
2020-05-08
Last updated
2020-05-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04381351. Inclusion in this directory is not an endorsement.

Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction (NCT04381351) · Clinical Trials Directory